These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 34614239

  • 1. Teduglutide in short bowel syndrome patients: A way back to normal life?
    Harpain F, Schlager L, Hütterer E, Dawoud C, Kirchnawy S, Stift J, Krotka P, Stift A.
    JPEN J Parenter Enteral Nutr; 2022 Feb; 46(2):300-309. PubMed ID: 34614239
    [Abstract] [Full Text] [Related]

  • 2. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
    Jeppesen PB, Pertkiewicz M, Forbes A, Pironi L, Gabe SM, Joly F, Messing B, Loth S, Youssef NN, Heinze H, Berghöfer P.
    Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
    [Abstract] [Full Text] [Related]

  • 3. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
    Jeppesen PB, Sanguinetti EL, Buchman A, Howard L, Scolapio JS, Ziegler TR, Gregory J, Tappenden KA, Holst J, Mortensen PB.
    Gut; 2005 Sep; 54(9):1224-31. PubMed ID: 16099790
    [Abstract] [Full Text] [Related]

  • 4. Long-Term Therapy With Teduglutide in Parenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series.
    Ukleja A, To C, Alvarez A, Lara LF.
    JPEN J Parenter Enteral Nutr; 2018 May; 42(4):821-825. PubMed ID: 29603279
    [Abstract] [Full Text] [Related]

  • 5. Experience with teduglutide treatment for short bowel syndrome in clinical practice.
    Pevny S, Maasberg S, Rieger A, Karber M, Blüthner E, Knappe-Drzikova B, Thurmann D, Büttner J, Weylandt KH, Wiedenmann B, Müller VA, Bläker H, Pascher A, Pape UF.
    Clin Nutr; 2019 Aug; 38(4):1745-1755. PubMed ID: 30145039
    [Abstract] [Full Text] [Related]

  • 6. Single-Center Experience with the Use of Teduglutide in Adult Patients with Short Bowel Syndrome.
    Lam K, Schwartz L, Batisti J, Iyer KR.
    JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):225-230. PubMed ID: 29505151
    [Abstract] [Full Text] [Related]

  • 7. Early use of teduglutide in paediatric patients with intestinal failure is associated with a greater response rate: a multicenter study.
    Germán-Díaz M, Alcolea A, Cabello V, Blasco-Alonso J, Rodríguez A, Galera R, García-Romero R, Romero C, González-Sacristán R, Redecillas-Ferreiro S, Moreno-Villares JM, Ramos-Boluda E.
    Eur J Pediatr; 2024 Aug; 183(8):3173-3182. PubMed ID: 38664251
    [Abstract] [Full Text] [Related]

  • 8. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
    Iyer KR, Kunecki M, Boullata JI, Fujioka K, Joly F, Gabe S, Pape UF, Schneider SM, Virgili Casas MN, Ziegler TR, Li B, Youssef NN, Jeppesen PB.
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):946-951. PubMed ID: 27875291
    [Abstract] [Full Text] [Related]

  • 9. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.
    Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B, O'Keefe SJ.
    Gut; 2011 Jul; 60(7):902-14. PubMed ID: 21317170
    [Abstract] [Full Text] [Related]

  • 10. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.
    Jeppesen PB, Gabe SM, Seidner DL, Lee HM, Olivier C.
    Gastroenterology; 2018 Mar; 154(4):874-885. PubMed ID: 29174926
    [Abstract] [Full Text] [Related]

  • 11. Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study.
    Joly F, Seguy D, Nuzzo A, Chambrier C, Beau P, Poullenot F, Thibault R, Armengol Debeir L, Layec S, Boehm V, Lallemand J, Quilliot D, Schneider SM.
    Clin Nutr; 2020 Sep; 39(9):2856-2862. PubMed ID: 31932048
    [Abstract] [Full Text] [Related]

  • 12. Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study.
    Jeppesen PB, Gabe SM, Seidner DL, Lee HM, Olivier C.
    Clin Nutr; 2020 Aug; 39(8):2479-2486. PubMed ID: 31784300
    [Abstract] [Full Text] [Related]

  • 13. Long-Term Outcomes With Teduglutide From a Single Center.
    Puello F, Wall E, Herlitz J, Lozano ES, Semrad C, Micic D.
    JPEN J Parenter Enteral Nutr; 2021 Feb; 45(2):318-322. PubMed ID: 32391948
    [Abstract] [Full Text] [Related]

  • 14. Long-term results of teduglutide treatment for chronic intestinal failure - Insights from a national, multi-centric patient home-care service program.
    Greif S, Maasberg S, Wehkamp J, Fusco S, Zopf Y, Herrmann HJ, Lamprecht G, Jacob T, Schiefke I, von Websky MW, Büttner J, Blüthner E, Tacke F, Pape UF.
    Clin Nutr ESPEN; 2022 Oct; 51():222-230. PubMed ID: 36184208
    [Abstract] [Full Text] [Related]

  • 15. Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure.
    Chen K, Mu F, Xie J, Kelkar SS, Olivier C, Signorovitch J, Jeppesen PB.
    JPEN J Parenter Enteral Nutr; 2020 Jan; 44(1):119-128. PubMed ID: 31006876
    [Abstract] [Full Text] [Related]

  • 16. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
    Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O'keefe SJ, Forbes A, Heinze H, Joelsson B.
    Gastroenterology; 2012 Dec; 143(6):1473-1481.e3. PubMed ID: 22982184
    [Abstract] [Full Text] [Related]

  • 17. Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials.
    Seidner DL, Gabe SM, Lee HM, Olivier C, Jeppesen PB.
    JPEN J Parenter Enteral Nutr; 2020 May; 44(4):697-702. PubMed ID: 31423614
    [Abstract] [Full Text] [Related]

  • 18. Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24-Week, Phase III Study.
    Kocoshis SA, Merritt RJ, Hill S, Protheroe S, Carter BA, Horslen S, Hu S, Kaufman SS, Mercer DF, Pakarinen MP, Venick RS, Wales PW, Grimm AA.
    JPEN J Parenter Enteral Nutr; 2020 May; 44(4):621-631. PubMed ID: 31495952
    [Abstract] [Full Text] [Related]

  • 19. Long-term teduglutide associated with improved response in pediatric short bowel syndrome-associated intestinal failure.
    Wales PW, Hill S, Robinson I, Raphael BP, Matthews C, Cohran V, Carter B, Venick R, Kocoshis S.
    J Pediatr Gastroenterol Nutr; 2024 Aug; 79(2):290-300. PubMed ID: 38873891
    [Abstract] [Full Text] [Related]

  • 20. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.
    Kochar B, Long MD, Shelton E, Young L, Farraye FA, Yajnik V, Herfarth H.
    J Clin Gastroenterol; 2017 Jul; 51(6):508-511. PubMed ID: 27433811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.